CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • Àå¼¼°æ
  • ¼Ò ¼Ó: ºÐ´çÂ÷º´¿ø
  • Àü¹®ºÐ¾ß : ºÎÀξÏ, ÇϺμÒÈ­±â¾Ï, Æó¾Ï, µÎ°æºÎ¾Ï, ³úÁ¾¾ç
  • Á÷ À§: ºÎ±³¼ö
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ
66 (±¹¿Ü)SCI "Use of lysates from pooled human mononuclear cells to activate CD3 T cells in humanized mice with low human cell engraftment efficiency"
65 (±¹¿Ü)SCIE Effect of elective internal mammary node irradiation on disease-free survival in women with node-positive breast cancer: A randomized phase 3 clinical trial
64 (±¹¿Ü)SCI Functional recovery by colon organoid transplantation in a mouse model of radiation proctitis.
63 (±¹¿Ü)SCIE Functional recovery by colon organoid transplantation in a mouse model of radiation proctitis
62 (±¹³»)SCIE "Distinct Repopulation Activity in Hu-Mice between CB- and LPB-CD34£« Cells by Enrichment of Transcription Factors "
61 (±¹¿Ü)SCIE Optimal treatment strategies for small cell carcinoma of the uterine cervix: A retrospective multi-center study (KROG 19-03)
60 (±¹¿Ü)SCI Optimization of Intracranial Germinoma Treatment: Radiotherapy Alone with Reduced Volume and Dose
59 (±¹¿Ü)SCI Preclinical platform for long-term evaluation of immuno-oncology drugs using hCD34+ humanized mouse model
58 (±¹¿Ü)SCI Clinical outcomes of hypofractionated radiotherapy for thyroid-associated ophthalmopathy
57 ±¹¿Ü Clinical outcomes of hypofractionated radiotherapy for thyroid-associated ophthalmopathy
ÀÌÀüÆäÀÌÁö À̵¿ 1 2 3 4 5 6 7 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729